Skip to content

Clinical trials

Phase 2/3 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 2/3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20071
20111
20143
20161
20171
20181
20211
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
United Therapeutics2
Assiut University1
Cabaletta Bio1
Daniels, Craig E., M.D.1
Franz Rischard, DO1
GlaxoSmithKline1
Huilan Zhang1
Human Adams1
Insmed Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial17
Scleroderma, Diffuse7
Hypertension, Pulmonary4
Dermatomyositis3
Polymyositis3
Connective Tissue Diseases2
Emphysema2
Idiopathic Pulmonary Fibrosis2
Mixed Connective Tissue Disease2
Pulmonary Fibrosis2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.